New antiherpetic nucleoside from a Basidiomycete;Nouveau nucleoside antiherpetique isole a partir d'un Basidiomycete

Comptes Rendus de l'Academie des Sciences - Serie III

Volumn 321, Issue 7, 1998, Pages 585-591

  Saboulard, Didier ^a   Gaspar, Alexandre ^a   Roussel, Bernard ^a   Villard, Jean ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Antiviral; Basidiomycetes; Herpesvirus; Macrocystidia cucumis (Pers. ex fr.) Heim; Nucleoside analogue

Indexed keywords

ANTIVIRUS AGENT; PURINE NUCLEOSIDE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BASIDIOMYCETES; CELL STRAIN BHK; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGUS GROWTH; HERPES SIMPLEX VIRUS 1; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALIA; BASIDIOMYCOTA; CRICETINAE; CUCUMIS; FUNGI; HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 1; MACROCYSTIDIA CUCUMIS;

EID: 0032127827     PISSN: 07644469     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0764-4469(98)80461-7     Document Type: Article

References (33)

1. [1] Darby G., A history of antiherpes research, Antiviral Chem. Chemother. 5 (1994) 3-9.
2. [2] De Clercq E., Antiviral for the treatment of herpesvirus infections, J. Antimicrob. Chem. 32 (1993) 121-132.
3. [3] De Clercq E., Descamps J., Verhelst G., Walker R. F., Jones A. S., Torrence P. F., Shugar D., Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus, J. Infect. Dis. 141 (1980) 563-574.
4. [4] Jeffries D., Barton S., Johnson R., Emery V., Issues in herpes managment, Antiviral. Chem. Chemother. 5 (1994) 23-29.
5. [5] Chatis P.A., Crumpacker C.S., Resistance of herpesviruses to antiviral drugs, Antimicrob. Agents Chemother. 36 (1992) 1589-1595.
6. [6] Field A.K., Biron K.K., 'The End of Innocence' revisited: Resistance of herpesviruses to antiviral drugs, Clin. Microbiol. Rev. 7 (1994) 1-13.
7. [7] Becker U., Anke T., Sterner O., A novel halogenated compound possessing antibiotic and cytotoxic activities isolated from the fungus Resinicium pinicola (J. Erikss.) Erikss. & Hjortst, Z. Naturforsch. 49 (1994) 772-774.
8. [8] Erkel G., Anke T., Velten R., Steglich W., Podoscyphic acid, a new inhibitor of Avian myeloblastosis virus and Moloney murine leukemia virus reverse transcriptase from a Podoscypha species, Z. Naturforsch. 46 (1991) 442-450.
9. [9] Erkel G., Anke T., Gimenez A., Steglich W., Clavicoronic acid, a novel inhibitor of reverse transcriptases from Clavicorona pyxidata (Pers. ex Fr.) Doty, J. Antibiotics. 45 (1992) 29-37.
10. [10] Kuschel A., Anke T., Velten R., Klostermeyer D., Steglich W., Konig B., The mniopetals, new inhibitors of reverse transcriptases from a Mniopetalum species (Basidiomycetes), J. Antibiotics 47 (1994) 733-739.
11. [11] Erkel G., Lorenzen K., Anke T., Velten R., Gimenez A., Steglich W., Kuehneromycins A and B, two new biological active compounds from a Tasmanian Kuehneromyces sp. (Strophariaceae, Basidiomycetes), Z. Naturforsch. 50 (1995) 1-10.
12. [12] Liberra K., Lindequist U., Marine fungi - a prolific ressource of biologically active natural products?, Pharmazie 9 (1995) 583-587.
13. [13] Mentel R., Meinsen D., Pilgrim H., Herrmann B., Lindequist U., In vitro antiviral effect of extracts of Kuehneromyces mutabilis on influenza virus, Pharmazie 49 (1994) 859-860.
14. [14] Leahy B.J., Christiansen K.J., Shellam G., Standardisation of a microplate in situ ELISA (mise-test) for the susceptibility testing of herpes simplex virus to acyclovir, J. Virol. Meth. 48 (1994) 93-108.
15. [15] Holt P.S., Buckley S., Norman J.O., Deloach J.R., Cytopatic effect of T-2 mycotoxin on cells in culture as determinated by a rapid colorimetric bio-assay, Toxicon. 26 (1988) 549-558.
16. [16] Saboulard D., Roussel B., Macher J.P., Gaspar A., Roesler P., Villard J. Int. Patent. 9.701.462. Feb. 5, 1997, McA, a new nucleoside analog and process for preparation thereof.
17. [17] Saboulard D., Isolation of a new nucleoside analog from the Basidiomycete Macrocystidia cucumis (Pers. ex Fr.) Heim., Ph.D. thesis, University of Lyon, France, 1997.
18. [18] Alrabiah F.A, Sacks S.L., New antiherpesvirus agents: their targets and therapeutic potential, Drugs 52 (1996) 17-32.
19. [19] De Clercq E., Antiviral activity spectrum and target of action of different classes of nucleoside analogues, Nucleosides Nucleotides 13 (1994) 1271-1295.
20. [20] Griffiths P.D., Spectrum of activity of antiherpesvirus drugs, Antiviral. Chem. & Chemother. 5 (1994) 17-22.
21. [21] Kimberlin D.W., Whitley R.J., Antiviral resistance: mechanisms, clinical significance, and future implication, J. Antimicrob. Chem. 37 (1996) 403-421.
22. [22] Pottage J.C., Kessler H.A., Herpes simplex virus resistance to acyclovir: clinical relevance, Inf. Ag. Dis. 4 (1995) 115-124.
23. [23] Epstein J.B., Scully C., Herpes simplex virus in immunocompromised patients: growing evidence of drug resistance, Oral Surg. Oral Med. Oral Pathol. 72 (1991) 47-50.
24. [24] Griffiths P.D., Closing remarks, Antiviral. Chem. & Chemother. 5 (1994) 39.
25. [25] De Clercq E., Holy A., Rosenberg I., Sakuma T., Balzarini J., Maudgal P.C., A novel selective broad-spectrum anti-DNA virus agent, Nature 323 (1986) 464-467.
26. [26] Darby G., Acyclovir - and beyond, J. Int. Med. Res. 22 (1994) 33-42.
27. [27] Griffiths P.D., Progress in the clinical management of herpesvirus infections, Antiviral. Chem. Chemother. 6 (1995) 191-209.
28. [28] Herdewijn P., Novel nudeoside strategies for anti-HIV and anti-HSV therapy, Antiviral Res. 19 (1992) 1-14.
29. [29] Schaeffer H. J., Beauchamp L., De Miranda P., Elion G. B., Bauer D. J., Collins P., 9-(2-hydroxyethoxymethyl)guanine activity against viruses of the herpes group, Nature 272 (1978) 583-585.
30. [30] Simon B., Anke T., Anders U., Neuhaus M., Hansske F., Collybial, a new antibiotic sesquiterpenoid from Collybia confluens (Basidiomycetes), Z. Naturforsch. 50 (1995) 173-180.
31. [31] Stadler M., Anke H., Sterner O., New nematicidal and antimicrobial compounds from the Basidiomycete Cheimonophyllum candidissimum (Berk & Curt.) Sing, J. Antibiotics 47 (1994) 1284-1289.
32. [32] Weber W., Anke T., Steffan B., Steglich W., Strobilurin E: a new cytostatic and antifungal (E)-b-methoxyacrylate antibiotic from Crepidotus fulvotomentosus Peck, J. Antibiotics 43 (1990) 207-212.
33. [33] Leonhardt K., Anke T., 6-methylpurine, 6-methyl-9-b-D-ribofuranosylpurine, and 6-hydroxymethyl-9-b-D-ribofuranosylpurine as antiviral metabolites of Collybia maculata (Basidiomycetes). Z. Naturforsch. 42 (1987) 420-424.